Michael Todisco Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael Todisco.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Todisco. Michael Todisco is Vice President, Controller in DUSA PHARMACEUTICALS INC ($DUSA).
Latest Insider Trading Transactions of Michael Todisco
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | D | 1.65 | 52,000 | 85,800 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | D | 1.22 | 27,800 | 33,916 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | D | 2.20 | 16,500 | 36,300 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | D | 3.37 | 20,000 | 67,400 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | D | 5.14 | 15,000 | 77,100 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | D | 6.75 | 4,000 | 27,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | D | 10.37 | 20,000 | 207,400 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Sell | U | 8.00 | 133,200 | 1,065,600 | 0 | 133.2 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Sell | U | 8.00 | 37,120 | 296,960 | 0 | 37.1 K to 0 (-100.00 %) |
May 11 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Payment of Exercise | F | 6.13 | 872 | 5,345 | 170,320 | 171.2 K to 170.3 K (-0.51 %) |
Mar 15 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Payment of Exercise | F | 5.86 | 2,203 | 12,910 | 171,192 | 173.4 K to 171.2 K (-1.27 %) |
Mar 09 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Grant | A | 0.00 | 80,000 | 0 | 173,395 | 93.4 K to 173.4 K (+85.66 %) |
Mar 09 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Payment of Exercise | F | 6.05 | 3,566 | 21,574 | 93,395 | 97 K to 93.4 K (-3.68 %) |
Mar 07 2012 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Payment of Exercise | F | 4.65 | 1,981 | 9,212 | 96,961 | 98.9 K to 97 K (-2.00 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | M | 1.22 | 27,800 | 33,916 | 0 | |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Sell | S | 5.89 | 500 | 2,945 | 98,942 | 99.4 K to 98.9 K (-0.50 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Sell | S | 5.90 | 3,000 | 17,703 | 99,442 | 102.4 K to 99.4 K (-2.93 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Sell | S | 5.90 | 5,000 | 29,507 | 102,442 | 107.4 K to 102.4 K (-4.65 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Sell | S | 5.91 | 5,000 | 29,534 | 107,442 | 112.4 K to 107.4 K (-4.45 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Sell | S | 5.91 | 5,000 | 29,537 | 112,442 | 117.4 K to 112.4 K (-4.26 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Sell | S | 5.91 | 2,500 | 14,775 | 117,442 | 119.9 K to 117.4 K (-2.08 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Sell | S | 5.91 | 300 | 1,773 | 119,942 | 120.2 K to 119.9 K (-0.25 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Sell | S | 5.93 | 1,100 | 6,523 | 120,242 | 121.3 K to 120.2 K (-0.91 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Sell | S | 5.94 | 5,000 | 29,676 | 121,342 | 126.3 K to 121.3 K (-3.96 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Sell | S | 5.94 | 300 | 1,782 | 126,342 | 126.6 K to 126.3 K (-0.24 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Sell | S | 5.94 | 100 | 594 | 126,642 | 126.7 K to 126.6 K (-0.08 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Buy | M | 1.22 | 27,800 | 33,916 | 126,742 | 98.9 K to 126.7 K (+28.10 %) |
May 11 2011 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Payment of Exercise | F | 5.80 | 873 | 5,063 | 98,942 | 99.8 K to 98.9 K (-0.87 %) |
Mar 14 2011 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Payment of Exercise | F | 4.15 | 2,207 | 9,159 | 99,815 | 102 K to 99.8 K (-2.16 %) |
Mar 08 2011 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Grant | A | 0.00 | 45,000 | 0 | 102,022 | 57 K to 102 K (+78.92 %) |
Mar 08 2011 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Payment of Exercise | F | 3.95 | 2,052 | 8,105 | 57,022 | 59.1 K to 57 K (-3.47 %) |
May 10 2010 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Payment of Exercise | F | 2.01 | 1,044 | 2,098 | 59,074 | 60.1 K to 59.1 K (-1.74 %) |
Mar 16 2010 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Payment of Exercise | F | 1.78 | 2,638 | 4,696 | 60,118 | 62.8 K to 60.1 K (-4.20 %) |
Mar 08 2010 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | A | 1.65 | 52,000 | 85,800 | 52,000 | |
Mar 08 2010 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Grant | A | 0.00 | 25,000 | 0 | 62,756 | 37.8 K to 62.8 K (+66.21 %) |
May 29 2009 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Payment of Exercise | F | 1.34 | 1,044 | 1,399 | 37,756 | 38.8 K to 37.8 K (-2.69 %) |
Mar 17 2009 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | A | 1.22 | 55,600 | 67,832 | 55,600 | |
Mar 17 2009 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Grant | A | 0.00 | 27,800 | 0 | 38,800 | 11 K to 38.8 K (+252.73 %) |
May 12 2008 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | A | 2.20 | 16,500 | 36,300 | 16,500 | |
May 12 2008 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Grant | A | 0.00 | 11,000 | 0 | 11,000 | 0 to 11 K |
Mar 21 2007 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | A | 3.37 | 20,000 | 67,400 | 59,000 | |
Nov 13 2006 | DUSA | DUSA PHARMACEUTICA ... | Todisco Michael | Vice President, Con ... | Option Exercise | A | 5.14 | 15,000 | 77,100 | 15,000 |
Page: 1